Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87,819,638
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
11,168,930
-
Shares change
-
-447,851
-
Total reported value, excl. options
-
$3,463,844
-
Value change
-
-$159,050
-
Number of buys
-
16
-
Number of sells
-
-16
-
Price
-
$0.3098
Significant Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q2 2025
54 filings reported holding CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q2 2025.
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,168,930 shares
of 87,819,638 outstanding shares and own 12.72% of the company stock.
Largest 10 shareholders include BIOS Capital Management, LP (6,000,000 shares), VANGUARD GROUP INC (1,304,350 shares), ACADIAN ASSET MANAGEMENT LLC (701,940 shares), Chescapmanager LLC (503,259 shares), Voss Capital, LP (450,000 shares), GEODE CAPITAL MANAGEMENT, LLC (368,720 shares), CM Management, LLC (250,000 shares), AMERICAN FINANCIAL GROUP INC (205,000 shares), Kestra Advisory Services, LLC (155,934 shares), and Sigma Planning Corp (147,990 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.